Bli medlem
Bli medlem

Du är här


myoscience: Jeffrey Gold Joins myoscience as President and Chief Operating Officer

REDWOOD CITY, Calif., April 23, 2014 (GLOBE NEWSWIRE) -- myoscience, inc. is
pleased to announce the addition of Jeffrey Gold to the team as President and
Chief Operating Officer (COO). Mr. Gold is an accomplished executive, having
held posts as Chief Executive for Velomedix and CryoVascular Systems as well
as Chief Operating Officer for CardioThoracic Systems.

"Jeff's leadership and extensive experience driving operational excellence
makes him an exceptional addition to myoscience as we expand our global
commercial presence in both aesthetic and therapeutic channels," said Clint
Carnell, CEO of myoscience.

Mr. Gold was most recently the President&CEO of Velomedix Inc, a venture
backed company that developed a unique technology for rapidly inducing
therapeutic hypothermia in patients undergoing severe acute cardiovascular
events, such as heart attack and cardiac arrest. Prior to Velomedix, Mr. Gold
was a Venture Partner for Longitude Capital where he focused on investments
in medical devices.

"I am thrilled to be joining myoscience at such an exciting point in their
growth," said Gold. "My previous experience and the current needs of the
company align perfectly and I look forward to guiding the business towards
further success."


Silicon Valley, California-based myoscience is a privately-held medical device
company committed to making its platform technology, Focused Cold TherapyTM,
the standard of care for the treatment of peripheral nerve conditions.
Focused Cold Therapy is the patented technology delivered by the ioveraº
system. The ioveraº system is currently approved in Europe and Canada for
temporary wrinkle reduction, temporary pain reduction and treatment of
dermatologic conditions, and is indicated in the United States for use in
pain management and general surgical use. For more information, please visit

The myoscience logo is available

© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are
trademarks of myoscience.

CONTACT: 1600 Seaport Blvd., Ste. 450 / Redwood City, CA
Tel: 650.474.2600 /
Peter Osborne /


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: myoscience via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.